While PD-L1-targeting PET approaches hold the potential to provide valuable insights into the assessment of heterogeneity and PD-L1 status throughout the whole body and predict response to ICI, their applicability in the context of gastric cancer imaging remains uncertain. The gene discussed is CD274; the disease is gastric cancer.